Journal of Medicinal Plants Research
Subscribe to JMPR
Full Name*
Email Address*

Article Number - 68F6B7955291


Vol.12(1), pp. 7-14 , January 2018
https://doi.org/10.5897/JMPR2017.6518
ISSN: 1996-0875


 Total Views: 0
 Downloaded: 0

Full Length Research Paper

A novel anti-triple negative breast cancer compound isolated from medicinal herb Myrothamnus flabellifolius



Jaspal Brar
  • Jaspal Brar
  • Department of Biological Sciences, University of the Sciences in Philadelphia, PA 19104, USA.
  • Google Scholar
Norman Fultang
  • Norman Fultang
  • Department of Biological Sciences, University of the Sciences in Philadelphia, PA 19104, USA.
  • Google Scholar
Kayla Askey
  • Kayla Askey
  • Department of Pharmacy, University of the Sciences in Philadelphia, PA 19104, USA.
  • Google Scholar
Maria Cristina Tettamanzi
  • Maria Cristina Tettamanzi
  • Department of Chemistry, Temple University, Philadelphia, PA 19122, USA.
  • Google Scholar
Bela Peethambaran
  • Bela Peethambaran
  • Department of Biological Sciences, University of the Sciences in Philadelphia, PA 19104, USA.
  • Google Scholar







 Received: 12 October 2017  Accepted: 12 December 2017  Published: 03 January 2018

Copyright © 2018 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0


Triple negative breast cancer (TNBC) is a disease that impacts millions of people around the world. There is an urgent need to find new therapies, specific to triple negative cancer cells with minimal effect on normal cells. This study explores the use of Myrothamnus flabellifolius as an anti-TNBC. Using High Performance Liquid Chromatography, the extract was fractionated and each fraction was tested against TNBC cells BT-549 and MDA-MB-231, and a non-malignant breast cell line MCF-10A. The results showed that fraction 7 inhibited the growth of TNBC cells starting at a dry weight concentration of 31.125 μg/mL while there was no significant cell death of the MCF-10A cell line. Using analytical techniques such as Mass Spectrometry (MS-MS) and Nuclear Magnetic Resonance (NMR), the major compound in fraction 7 was determined to be a derivative of galloyl glucose hexahydroxydiphenic acid. The results suggest that this novel compound is the primary anti-TNBC compound in M. flabellifolius and might be a potential candidate for targeted TNBC therapy.
 
Key words: Triple negative breast cancer, Myrothamnus flabellifolius, natural products, galloyl glucose hexahydroxydiphenic acid derivative.

Anders C, Carey LA (2008). Understanding and Treating Triple-Negative Breast Cancer. J. Oncol. 22(11):1233-1243.

 

Badiab A, Nabbie F, Tettamanzi MC, Patel N, Jain N, Peethambaran B (2016). Specific Cytotoxicity of a Novel Arbutin Derivative from Myrothamnus flabellifolia against Human Leukemia Cells. J. Med. Plant Res. 10:396-402.
Crossref

 
 

Bokesch HR, McKee TC, Currens MJ, Gulakowski RJ, McMahon JB, Cardellina JH, Boyd MR (1996). HIV-inhibitory gallotannins from Lepidobotrysstaudtii. Nat. Prod. Lett. 8:133-136.
Crossref

 
 

Chagonda LS, Makanda C, Chalchat JC. (1999). Essential oils of four wild and semi-wild plants from Zimbabwe: Colophospermummopane (Kirk ex Benth.) Kirk ex Leonard, Helichrysum splendidum (Thunb.) Less, Myrothamnus flabellifolia (Welw.) and Tagetes minuta L. J. Essent. Oil. Res. 11:573-578.
Crossref

 
 

Da Cunha AP, Roque OR, da Cunha MA (1974). Identificação e dosagem dos principais constituintes do óleo essencial do Myrothamnus flabellifolia Welm de Angola. Boletim Facul. Farm. Ecimera Edicao Cien. 34:49-61.

 
 

Dhillon J, Miller V, Carter J, Badiab A, Tang CN, Huynh A, Peethambaran P (2014). Apoptosis-inducing potential of Myrothamnus flabellifolia an edible medicinal plant, on human myeloid leukemia HL-60 cells. Int. J. Appl. Res. Nat. Prod. 7(1):28-32.

 
 

Donepudi MS, Kondapalli K, Amos SJ, Venkanteshan P (2014). Breast Cancer Statistics and Markers. J. Can. Res. Ther. 10(3):506-511.

 
 

Engelhardt C, Petereit F, Lechtenberg M, Liefländer-Wulf U, Hensel A (2016). Qualitative and quantitative phytochemical characterization of Myrothamnus flabellifolia Welw. Fitoterapia 114:69-80.
Crossref

 
 

Hua KT, Way TD, Lin JK (2006). Pentagalloylglucose inhibits estrogen receptor α by lysosome‐dependent depletion and modulates ErbB/PI3K/Akt pathway in human breast cancer MCF‐7 cells. Mol. Carcinog. 45(8):551-560.
Crossref

 
 

Huh JE, Lee EO, Kim MS, Kang KS, Kim CH, Cha BC, Surh YJ, Kim SH (2005). Penta-O-galloyl-beta-D-glucose suppresses tumor growth via inhibition of angiogenesis and stimulation of apoptosis: roles of cyclooxygenase-2 and mitogen-activated protein kinase pathways. Carcinogenesis 26(8):1436-1445.
Crossref

 
 

Hu H, Lee HJ, Jiang C, Zhang J, Wang L, Zhao Y, Xiang Q, Lee EO, Kim SH, Lü J (2008). Penta-1, 2, 3, 4, 6-O-galloyl-β-d-glucose induces p53 and inhibits STAT3 in prostate cancer cells in vitro and suppresses prostate xenograft tumor growth in vivo. Mol. Cancer. Ther. 7(9):2681-2691.
Crossref

 
 

Kim HA, Lee RA, Moon BI, Choe KJ (2009). Ellagic acid shows different anti-proliferative effects between the MDA-MB-231 and MCF-7 human breast cancer cell lines. J. Breast Cancer 2(2):85-91.
Crossref

 
 

Koonjul PK (1999). Investigating the mechanisms of desiccation tolerance in the resurrection plant Myrothamnus flabellifolia (Welw.). PhD Thesis, University of Cape Town, South Africa. Available at: 

View

 
 

Manna S, Holz MK (2016). Tamoxifen Action in ER-Negative Breast Cancer. Sign. Transduct. Insights 5:1-7.
Crossref

 
 

Moore JP, Farrant JM, Lindsey GG, Brandt WF (2005a). The South African and Namibian populations of resurrection plant Myrothamnus flabellifolius are genetically distinct and display variation in their galloylquinic acid composition. J. Chem. Ecol. 31:2823-2834.
Crossref

 
 

Moore JP, Westall KL, Ravenscroft N, Farrant JM, Lindsey GG, Brandt WF (2005b). The predominant polyphenol in the leaves of the resurrection plant Myrothamnus flabellifolius, 3,4,5-tri-O-galloylquinic acid, protects membranes against desiccation and free radical-induced oxidation. Biochem. J. 385:301-308.
Crossref

 
 

Moore JP, Lindsey GG, Farrant JM, Brandt WF (2007). An Overview of the Biology of the Desiccation-tolerant Resurrection Plant Myrothamnus flabellifolia. Ann. Bot. 99(2):211-217.
Crossref

 
 

Gescher K, Kühn J, Lorentzen E, Hafezi W, Derksen A, Deters A, Hensel A (2011). Proanthocyanidin-enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration. J. Ethnopharmacol. 134(2):468-474.
Crossref

 
 

Gibbs RD (1974). Chemotaxonomy of flowering plants, Vol. 3. Montreal: McGill-Queens University Press.
Crossref

 
 

Pal S, Lüchtenborg M, Davies EA, Jack RH (2014). The Treatment and Survival of Patients with Triple Negative Breast Cancer in a London population. J. Springer Plus. 3:553.
Crossref

 
 

Serna DN, Martínez JH (2015). Phenolics and Polyphenolics from Melastomataceae Species. Molecules 20(10):17818-17847.
Crossref

 
 

Viljoen AM, Klepser ME, Ernst EJ, Keele D, Roling E, Van Vuuren S, Demirci B, Baser KH, Van Wyk BE, Jäger AK (2002). The composition and antimicrobial activity of the essential oil of the resurrection plant Myrothamnus flabellifolia. S. Afr. J. Bot. 68(1):100-105.
Crossref

 
 

Wahba HA, El-Hadaad HA (2015). Current Approaches in Treatment of Triple-negative Breast Cancer. Can. Biol. Med. 12(2):106-116.

 

 


APA Brar, J., Fultang, N., Askey, K., Tettamanzi, M. C., & Peethambaran, B. (2018). A novel anti-triple negative breast cancer compound isolated from medicinal herb Myrothamnus flabellifolius. Journal of Medicinal Plants Research, 12(1), 7-14.
Chicago Jaspal Brar, Norman Fultang, Kayla Askey, Maria Cristina Tettamanzi and Bela Peethambaran. "A novel anti-triple negative breast cancer compound isolated from medicinal herb Myrothamnus flabellifolius." Journal of Medicinal Plants Research 12, no. 1 (2018): 7-14.
MLA Jaspal Brar, et al. "A novel anti-triple negative breast cancer compound isolated from medicinal herb Myrothamnus flabellifolius." Journal of Medicinal Plants Research 12.1 (2018): 7-14.
   
DOI https://doi.org/10.5897/JMPR2017.6518
URL http://academicjournals.org/journal/JMPR/article-abstract/68F6B7955291

Subscription Form